Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice

Shu-lian Li1, Marpadga A Reddy, Qiangjun Cai

  • 1Department of Diabetes, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.

Diabetes
|August 29, 2006
PubMed

Insights

Diabetic db/db mice exhibit heightened inflammatory responses in vascular cells, including macrophages and smooth muscle cells. This suggests a preactivated, proatherogenic phenotype contributing to diabetic vascular dysfunction and atherosclerosis.

Area of Science:

  • Vascular Biology
  • Immunology
  • Metabolic Diseases

Background:

  • Diabetes mellitus is linked to increased inflammation and cardiovascular issues like atherosclerosis.
  • The behavior of vascular cells in animal models of diabetes requires further investigation.

Purpose of the Study:

  • To investigate if macrophages and vascular smooth muscle cells (VSMCs) from diabetic db/db mice show enhanced proatherogenic responses compared to controls.
  • To explore the molecular mechanisms underlying these cellular responses in a diabetic milieu.

Main Methods:

  • Comparison of gene expression for inflammatory markers in macrophages and VSMCs from db/db and db/+ mice.
  • Assessment of oxidant stress, signaling kinase activation, and transcription factor activity (NF-κB, CREB).
  • Evaluation of VSMC migration and adhesion properties.

Main Results:

  • Macrophages and VSMCs from db/db mice displayed significantly increased expression of inflammatory cytokines, chemokines, and lipid-generating enzymes.
  • db/db derived vascular cells showed elevated oxidant stress, activated signaling pathways, and transcription factors.
  • VSMCs from db/db mice exhibited enhanced migration and adhesion capabilities.

Conclusions:

  • Vascular cells from diabetic db/db mice possess a preactivated, proinflammatory phenotype.
  • This phenotype contributes to the pathogenesis of diabetic vascular dysfunction and atherosclerosis.
  • The diabetic environment, potentially including hyperglycemic memory, induces aberrant vascular cell behavior.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...